Pushing the limits of targeted therapy in chronic myeloid leukaemia

被引：250

作者：

O'Hare, Thomas ^{[1
]}

Zabriskie, Matthew S. ^{[1
]}

Eiring, Anna M. ^{[1
]}

Deininger, Michael W. ^{[1
]}

机构：

[1] Univ Utah, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

来源：

NATURE REVIEWS CANCER | 2012年 / 12卷 / 08期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; KINASE DOMAIN MUTATIONS; DIAGNOSED CHRONIC-PHASE; BCR-ABL1; LYMPHOBLASTIC-LEUKEMIA; COMPLETE MOLECULAR REMISSION; PATIENTS RECEIVING IMATINIB; CHROMOSOME-POSITIVE CELLS; BCR-ABL INHIBITORS; STEM-CELLS; TYROSINE KINASE;

D O I：

10.1038/nrc3317

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tyrosine kinase inhibitor (TKI) therapy targeting the BCR-ABL1 kinase is effective against chronic myeloid leukaemia (CML), but is not curative for most patients. Minimal residual disease (MRD) is thought to reside in TKI-insensitive leukaemia stem cells (LSCs) that are not fully addicted to BCR-ABL1. Recent conceptual advances in both CML biology and therapeutic intervention have increased the potential for the elimination of CML cells, including LSCs, through simultaneous inhibition of BCR-ABL1 and other newly identified, crucial targets.

引用

页码：513 / 526

页数：14

共 167 条

[1] Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation [J].

Abrahamsson, Annelie E. ;

Geron, Ifat ;

Gotlib, Jason ;

Dao, Kim-Hien T. ;

Barroga, Charlene F. ;

Newton, Isabel G. ;

Giles, Francis J. ;

Durocher, Jeffrey ;

Creusot, Remi S. ;

Karimi, Mobin ;

Jones, Carol ;

Zehnder, James L. ;

Keating, Armand ;

Negrin, Robert S. ;

Weissman, Irving L. ;

Jamieson, Catriona H. M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3925-3929

[2] ERK2, but Not ERK1, Mediates Acquired and "De novo" Resistance to Imatinib Mesylate: Implication for CML Therapy [J].

Aceves-Luquero, Clara I. ;

Agarwal, Anupriya ;

Callejas-Valera, Juan L. ;

Arias-Gonzalez, Laura ;

Esparis-Ogando, Azucena ;

del Peso Ovalle, Luis ;

Bellon-Echeverria, Itxaso ;

de la Cruz-Morcillo, Miguel A. ;

Galan Moya, Eva M. ;

Moreno Gimeno, Inmaculada ;

Gomez, Juan C. ;

Deininger, Michael W. ;

Pandiella, Atanasio ;

Sanchez Prieto, Ricardo .

PLOS ONE, 2009, 4 (07)

[3] Allosteric inhibitors of Bcr-abl-dependent cell proliferation [J].

Adrián, FJ ;

Ding, Q ;

Sim, TB ;

Velentza, A ;

Sloan, C ;

Liu, Y ;

Zhang, GB ;

Hur, W ;

Ding, S ;

Manley, P ;

Mestan, J ;

Fabbro, D ;

Gray, NS .

NATURE CHEMICAL BIOLOGY, 2006, 2 (02) :95-102

[4] An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia [J].

Agarwal, A. ;

Eide, C. A. ;

Harlow, A. ;

Corbin, A. S. ;

Mauro, M. J. ;

Druker, B. J. ;

Corless, C. L. ;

Heinrich, M. C. ;

Deininger, M. W. .

LEUKEMIA, 2008, 22 (12) :2269-2272

[5] Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients [J].

Akel, S ;

Kolialexi, A ;

Mavrou, A ;

Metaxotou, C ;

Loukopoulos, D ;

Yataganas, X .

CANCER GENETICS AND CYTOGENETICS, 2000, 122 (02) :93-100

[6] Significance of Suboptimal Response to Imatinib, as Defined by the European LeukemiaNet, in the Long-Term Outcome of Patients With Early Chronic Myeloid Leukemia in Chronic Phase [J].

Alvarado, Yesid ;

Kantarjian, Hagop ;

O'Brien, Susan ;

Faderl, Stefan ;

Borthakur, Gautam ;

Burger, Jan ;

Wierda, William ;

Garcia-Manero, Guillermo ;

Shan, Jianqin ;

Cortes, Jorge .

CANCER, 2009, 115 (16) :3709-3718

[7] Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia [J].

Apperley, Jane F. .

LANCET ONCOLOGY, 2007, 8 (11) :1018-1029

[8] Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL [J].

Azam, M ;

Latek, RR ;

Daley, GQ .

CELL, 2003, 112 (06) :831-843

[9] Activation of tyrosine kinases by mutation of the gatekeeper threonine [J].

Azam, Mohammad ;

Seeliger, Markus A. ;

Gray, Nathanael S. ;

Kuriyan, John ;

Daley, George Q. .

NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (10) :1109-1118

[10] Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet [J].

Baccarani, Michele ;

Saglio, Giuseppe ;

Goldman, John ;

Hochhaus, Andreas ;

Simonsson, Bengt ;

Appelbaum, Frederick ;

Apperley, Jane ;

Cervantes, Francisco ;

Cortes, Jorge ;

Deininger, Michael ;

Gratwohl, Alois ;

Guilhot, Frangois ;

Horowitz, Mary ;

Hughes, Timothy ;

Kantarjian, Hagop ;

Larson, Richard ;

Niederwieser, Dielger ;

Silver, Richard ;

Hehlmann, Rudiger .

BLOOD, 2006, 108 (06) :1809-1820

← 1 2 3 4 5 6 7 8 9 10 →